Psoriatic arthritis: diagnosis, pathogenesis, and emerging therapies

Affiliations

¹ Department of Rheumatology and Clinical Immunology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA. Electronic address: Iadamopo@bidmc.harvard.edu.
² Ruhr-University Bochum, Rheumazentrum Ruhrgebiet Herne, Germany.
³ Division of Allergy, Immunology, and Rheumatology, Box 695, University of Rochester Medical Center, Rochester, NY 14643, USA.

Iannis E Adamopoulos et al. Trends Mol Med. 2025 Jul.

. 2025 Jul;31(7):682-683.

doi: 10.1016/j.molmed.2025.05.003. Epub 2025 Jun 10.

¹ Department of Rheumatology and Clinical Immunology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA. Electronic address: Iadamopo@bidmc.harvard.edu.
² Ruhr-University Bochum, Rheumazentrum Ruhrgebiet Herne, Germany.
³ Division of Allergy, Immunology, and Rheumatology, Box 695, University of Rochester Medical Center, Rochester, NY 14643, USA.

No abstract available

Keywords: innate immunity; interleukin 17; interleukin 23; psoriatic arthritis.

Conflict of interest statement

Declaration of interests The authors have no conflicts of interest.

1. Ritchlin C and Adamopoulos IE (2021) Axial spondyloarthritis: new advances in diagnosis and management. BMJ 372, m4447. 10.1136/bmj.m4447 - DOI - PubMed
1. Mauro D et al. (2023) The bone marrow side of axial spondyloarthritis. Nat Rev Rheumatol 19, 519–532. 10.1038/s41584-023-00986-6 - DOI - PubMed
1. Navid F et al. (2024) HLA-B27 and spondyloarthritis: at the crossroads of innate and adaptive immunity. Nat Rev Rheumatol. 10.1038/s41584-024-01189-3 - DOI - PubMed
1. Schett G et al. (2022) Psoriatic arthritis from a mechanistic perspective. Nat Rev Rheumatol 18, 311–325. 10.1038/s41584-022-00776-6 - DOI - PubMed
1. Furuya H et al. (2023) Interleukin-23 Regulates Inflammatory Osteoclastogenesis via Activation of CLEC5A(+) Osteoclast Precursors. Arthritis Rheumatol 75, 1477–1489. 10.1002/art.42478 - DOI - PMC - PubMed